Hankook Tire Co. (161390)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 60,100.00 |
|---|---|
| 52-week range | 43,700.00 – 78,400.00 |
| Return, 1 month / 3 months | +4.9% / −20.6% |
| Return, 1 year / 3 years | +40.1% / +83.0% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 51.4% |
| Worst drawdown (1 year) | -29.7% |
| Average daily value traded | 17,932.02M KRW |
| Dividend yield | 4.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hankook Tire is a South Korean tyre maker based in Seoul. It designs and produces tyres for passenger cars, light trucks, buses and commercial vehicles, along with tyres for motorsport use. The company supplies vehicle manufacturers with original equipment tyres and also sells replacement tyres to drivers and distributors through its Hankook brand. Its customers span car owners, fleet operators and automakers in markets around the world.
The shares are listed on the Korea Stock Exchange in Korea under the code 161390, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hankook Tire Co. (161390) trades on the Korea Stock Exchange in Korea. It last closed at KRW 60,100.00 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 130 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.1% and over the last three months it fell 20.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -4.2% | ||
| From 52-week high | -21.6% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -20.6% | ||
| 6-month return | -5.1% | ||
| 12-month return, skipping the last month | 33.6% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 51.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.7% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 17,932.02M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | +4.9% |
| 3 months | −20.6% |
| 6 months | −5.1% |
| 1 year | +40.1% |
| 3 years | +83.0% |
| 5 years | +67.0% |
Signals
| 50-day / 200-day average | 63,333.35 / 62,744.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,517.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Aug 2026 | KRW 900.0000 |
| 30 Mar 2026 | KRW 1,500.0000 |
| 3 Sep 2025 | KRW 800.0000 |
| 28 Mar 2025 | KRW 2,000.0000 |
| 27 Dec 2023 | KRW 1,300.0000 |
| 28 Dec 2022 | KRW 800.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.